Jamie L. Miller, Pharm.D., BCPS, BCPPS, FPPAG

---

Publications & Presentations

126. Gish E C, Miller J L, Gildon B, Johnson P N. Lofexidine, an {alpha}2-receptor agonist for opioid detoxification. The Annals of pharmacotherapy. 2010; 44 : 343-51

127. Miller J L, Johnson P N, Harrison D, Hagemann T M. Evaluation of inpatient admissions and potential antimicrobial and analgesic dosing errors in overweight children. The Annals of pharmacotherapy. 2010; 44 : 35-42

128. Miller J L, Allen C, Johnson P N. Neurologic withdrawal symptoms following abrupt discontinuation of a prolonged dexmedetomidine infusion in a child. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2010; 15 : 38-42

129. Miller J L, Gormley A K, Johnson P N. Pantoprazole-induced thrombocytopenia. Indian journal of pediatrics. 2009; 76 : 1278-9

130. Gildon B, Benefield R J, Miller J L, Johnson P N. Alpha2-receptor agonists for treatment and prevention of iatrogenic opioid abstinence syndrome in critically ill patients. The Annals of pharmacotherapy. 2009; 43 : 1506-11

Grants

1. Selenium Pharmacokinetics and Pharmacodynamics of Infants with Intestinal Failure a Prospective Cohort Study. Misc Non-Federal. Start Date: 2025. End Date: 2026.

2. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.

3. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.

4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

5. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

Awards and Honors

1. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2024.


2. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2024.


3. American Society of Health-System Pharmacists. Fellow of American Society of Health-System Pharmacists. Date: 2024.


4. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2023.


5. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2023.

Education

1. Degree: PharmD. Southwestern Oklahoma State University. Date: 2006.


2. Degree: BS. Trevecca Nazarene University. Date: 2002.

Administrative Assignments

1. Role: Department Vice-Chair. Scope: Department. Date: 2021.
Read More